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Abstract
Background: Limited data exist documenting the degree to which travelers are inconvenienced by travelers’
diarrhea (TD). We performed a prospective follow-up study at the travel clinic of Leiden University Medical Center
in The Netherlands to determine the degree of inconvenience and to determine how experiencing TD affects
travelers’ perception.
Methods: Healthy adults who intended to travel to the (sub)tropics for less than two months were invited to take
part. Participants filled out a web-based questionnaire before departure and after returning home. TD was defined
as three or more unformed stools during a 24-hour period.
Results: 390 of 776 Eligible travelers completed both questionnaires. Participants’ median age was 31 years and
mean travel duration 23 days. Of 160 travelers who contracted TD (incidence proportion 41%, median duration of
TD episode 2.5 days) the majority (107/160, 67%) could conduct their activity program as planned despite having
diarrhea. However, 21% (33/160) were forced to alter their program and an additional 13% (20/160) were confined
to their accommodation for one or more daylight days; 53 travelers (33%) used loperamide and 14 (9%) an
antibiotic. Eight travelers (5%) consulted a physician for the diarrheal illness. When asked about the degree of
inconvenience brought on by the diarrheal illness, 39% categorized it as minor or none at all, 34% as moderate
and 27% as large or severe. In those who regarded the episode of TD a major inconvenience, severity of
symptoms was greater and use of treatment and necessity to alter the activity program were more common.
Travelers who contracted travelers’ diarrhea considered it less of a problem in retrospect than they had thought it
would be before departure.
Conclusion: Conventional definitions of TD encompass many mild cases of TD (in our study at least a third of all
cases) for which treatment is unlikely to provide a significant health benefit. By measuring the degree of
inconvenience brought on by TD, researchers and policy makers may be able to better distinguish ‘significant TD’
from mild TD, thus allowing for a more precise estimation of the size of the target population for vaccination or
stand-by antibiotic prescription and of the benefit of such measures.
Background
Travelers’ diarrhea (TD) affects 20-50% of travelers from
industrialized regions to developing countries [1-3]. Many
travel medicine experts recommend loperamide for mild
TD and self-administered antibiotic treatment in case of
moderate or severe TD [4-6]. Compared with placebo,
antibiotics shorten the duration of diarrhea by 0.7-1.5 days
and reduce the number of unformed stools per 24 hour
time interval by 1.6 on the first day of treatment, 2.1 on
the second day, and 1.4 on the third day [7]. No studies
e x i s tt h a th a v ea s s e s s e dt ow h a te x t e n te a r l ya n t i b i o t i c
treatment significantly impacts the subjective and objective
(i.e. incapacitation) degree of inconvenience due to TD.
The benefit of prescribing all travelers with antibiotics for
self-treatment in case of TD should be weighed against
the drawbacks. Although side-effects are seldom serious,
use of an antibiotic makes a person more susceptible to
colonization by drug resistant Enterobacteriaceae [8,9].
Furthermore, large-scale use and disposal of antibiotics in
the environment induces resistance among pathogens. For
these reasons, there are pro- and opponents regarding
routine pre-travel prescription of stand-by antibiotics for
travelers [10]. An argument favoring routine prescription
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antibiotics abroad, many being false. A central argument
for those who advocate wide-spread use of antibiotics for
TD is that it can cause considerable inconvenience, ruin
holidays and cause financial loss and that it may cause
chronic gastro-intestinal complaints [6,11,12]. A number
of studies describe the impact of TD on quality of life and
incapacitation [2,3,13-15]. Of those with TD, 20-45% is
unable to pursue planned activities for 1 day and the qual-
i t yo fl i f ei sa f f e c t e d ,m o s t l yw ith regard to the ability to
participate in leisure activities, sexual activity, and the feel-
ing of general well-being [13]. The present prospective fol-
low-up study was designed to determine the degree of
subjective and objective inconvenience that Dutch trave-
lers experience when they contract diarrhea during travel
to the (sub)tropics. In addition we determined how an epi-
sode of TD affects travelers’ perception of TD and we
explored risk factors.
Methods
Design and study population
This was a single-center prospective cohort study at the
travel clinic of Leiden University Medical Center in The
Netherlands. It was conducted from March until Novem-
ber 2010. Healthy adults who visited the travel clinic and
intended to travel to the (sub)tropics were invited to take
part by way of an informative letter. The letter was
attached to a standard intake form that clients fill out
before their appointment at the travel clinic. All who read
the letter were asked to fill out an accompanying answer
card that provided three options: (i) “yes, I want to partici-
pate”, (ii) “no, I do not want to participate”, (iii) “I am not
eligible to participate”. Exclusion criteria were: travel dura-
tion of more than two months, use of systemic immuno-
suppressive medication, history of inflammatory bowel
disease or insulin-dependent diabetes mellitus. Partici-
pants were sent two web-based questionnaires via e-mail,
the first before departure, and the second a week after
returning home. In The Netherlands no formal approval
by a medical ethics committee is required for this kind of
questionnaire study.
The pre-travel consult was not different for participants
than for other travelers. All received a brochure about pre-
ventive measures and self-treatment with loperamide and
oral rehydration solution in case of TD. In The Nether-
lands, pre-travel supply of antibiotics for self-treatment in
case of TD is restricted to high-risk travelers who are at
increased risk of severe infection or dehydration, and to
those who travel to remote areas with limited access to
health care facilities [16].
Definition of travelers’ diarrhea
In order to avoid misinterpretation we used a straight-
forward definition of TD. In the questionnaires TD was
defined as: the passage of three or more unformed
stools during a 24-hour period with or without addi-
tional symptoms [14,17]. In the analyses, ‘classic TD’
was defined separately as: the passage of three or more
unformed stools during a 24-hour period with one or
more symptoms of enteric disease such as nausea,
abdominal cramps, vomiting, fever or fecal urgency
[18,19].
Questionnaires
The first questionnaire (Q1) consisted of questions on past
travel to the tropics, past experience with TD and past
inconvenience due to TD. In addition, we surveyed the
incidence of diarrhea among participants during a two-
month period in The Netherlands and during past travel
to the tropics. The second questionnaire (Q2) was sent
within a week after returning home and dealt with travel
characteristics, the incidence of TD and accompanying
symptoms, the use of anti- diarrheal medication, the inci-
dence of other health problems, the incidence of TD
among travel companions, health-care use for TD and
subjective and objective inconvenience due to TD. The
objective degree to which TD inconvenienced travelers
was measured by asking: “To what extent were you incon-
venienced by your episode of diarrhea?”. Participants
could choose one of the following answers: (i) “Ii n t e r -
rupted my journey and returned home due to the diarrhea
and abdominal complaints”, (ii) “I was ill, I altered my
activity program and stayed indoors for one or more days
due to the diarrhea and abdominal complaints”, (iii) “I
altered my activity program due to the diarrhea and
abdominal complaints”,o r( i v )“despite the episode of diar-
rhea, I could take part in all planned activities”. Some tra-
velers may have had more than one episode of TD. All
questions concerning symptoms of TD and the degree of
inconvenience due to TD pertained to the most severe
episode. The subjective degree of inconvenience due to
TD was measured by asking: “To what degree did you
experience inconvenience due to the episode of diarrhea?”.
Participants could choose from the following answers: (i)
“no inconvenience”,( i i )“a minor degree of inconvenience”,
(iii) “a moderate degree of inconvenience”,( i v )“al a r g e
degree of inconvenience”,o r( v )“a severe degree of incon-
venience”. In addition, we explored how an episode of TD
during travel changed travelers’ own perception of TD.
This was done as follows. Before departure we asked: “If
you were to contract travelers’ diarrhea with fecal urgency
and abdominal cramps for three days, how large a problem
would you consider this to be?”.( i )“no problem”, (ii) “a
small problem”, (iii) “neither a small nor a large problem”,
(iv) “a large problem”,( v )“av e r yl a r g ep r o b l e m ”.A f t e r
returning home all travelers were presented a similar sce-
nario pertaining to a hypothetical future travel. We
thought that the answer to this question would change in
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same in those who had not. The overall direction in which
the answer changes, reflects how experiencing an episode
of TD influences the perception of TD. We piloted the
questionnaire among travelers, acquaintances and staff of
the department of Clinical Epidemiology at Leiden Univer-
sity Medical Center.
Data editing
Travel destination was categorized according to the United
Nations (UN) International Migrant Stock [20]. Travel
destination was also categorized according to the UN
Human Development Index (HDI) value (0 to 1) and UN
HDI category (high, medium, low) [21]. The HDI is based
upon indicators of life expectancy, education and living
standards. If a participant visited more than one country,
t h eH D Iv a l u eo ft h ec o u n t r yw i t ht h el o w e s tH D Iw a s
used. In regression analyses, continuous variables that
were not linearly associated with the dependent variable
were categorized based on exploratory analyses of the con-
tinuous data in small categories to see at which values of
the continuous variable the regression coefficient changed.
Sample size
The sample size was based on the rule of thumb that 10
cases are needed for each covariate that is introduced in a
logistic regression model [22]. Based on an assumed inci-
dence proportion (i.e. the incident number of cases in rela-
tion to the size of the population) for TD of 25% we
estimated that 400 travelers were needed to be able to
introduce a maximum of 10 separate covariates in a logis-
tic regression analysis.
Regression analyses
In a prediction model we explored which variables signif-
icantly increased the odds of contracting classic TD.
Categorical variables were analyzed with c
2-tests and
continuous variables with t-tests. Variables with p <0 . 2
were entered in a multiple logistic regression model
based on maximum likelihood estimation. Interaction
terms were not entered in the model to prevent overfit-
ting and because interaction was deemed unlikely. Cook’s
distance values, leverage values and standardized resi-
duals were examined to detect cases that might be influ-
encing the model disproportionately. Variance inflation
factors were examined to test whether any covariates
were highly collinear. The relative strength of each cov-
ariate in the final regression model was determined by
computing the delta in Nagelkerke R
2 when one covariate
was deleted and by dividing delta by the final model’s
Nagelkerke R
2. In another logistic regression analysis
restricted to travelers who had TD, we explored which
person- and travel characteristics predicted incapacita-
t i o nd u et oT D .I nat h i r dm o d e lw ee x p l o r e dw h i c h
symptoms predicted incapacitation due to TD. All ana-
lyses were done using PASW Statistics, version 18.0,
IBM
®. Statistical significance was defined as a p-value <
0.05.
Results
Study population and travel characteristics
At our travel clinic 776 of 1,000 travelers fulfilled the
inclusion criteria of which 406 provided informed consent
(response rate 52%). Of the 224 people who were not eligi-
ble to participate, travel duration in excess of two months
was the most common exclusion criterion. Three hundred
and ninety travelers completed both the pre- and post-
travel questionnaire (follow-up rate 96%) (Figure 1). The
median age was 31 years (IQR 24-50 years). The majority
was female (65%), and had completed higher education
(62%) (i.e. a Bachelor degree). Person- and travel charac-
teristics are described in Table 1 and 2. Tourism was the
main reason for travel and South-eastern Asia was visited
most frequently (31%). The mean travel duration was
23 days (range 4-57 days). At the pre-travel consult, 27 tra-
velers (7%) received a stand-by antibiotic prescription
(ciprofloxacin or azitromycin). In total 335 travelers (86%)
carried treatment for TD in their travel-kit, mainly lopera-
mide (282/390, 72%), oral rehydration solution (229/390,
59%) or activated carbon (83/390, 21%).
Travelers’ diarrhea: incidence, symptoms, treatment and
risk factors
One hundred and sixty travelers (160/390, 41%) (26% per
any two weeks of stay) contracted TD. Of these 160 trave-
lers with TD, 16 did not have any accompanying symptom
of enteric disease such as nausea, abdominal cramps,
vomiting, fever or fecal urgency, making the incidence
proportion of classic TD 37% (144/390). The overall TD
Incidence Rate (IR) was 1.78 cases per 100 person days of
travel (pdt). IRs were highest for travelers to Northern-
Africa (3.95/100 pdt) and South-central Asia (2.55/100
pdt) (Table 2). Most affected travelers had typical symp-
toms: watery stools (138/160, 86%), fecal urgency (114/
160, 71%) and abdominal discomfort (123/160, 77%)
(Table 3). The diarrheal episode lasted a median of 2.5
days (IQR 1-2.5 days). Sixty-five of 160 travelers with TD
(41%) started treatment with an anti-motility agent or an
antibiotic: 26% (41/160) used loperamide only, 4% (6/160)
activated carbon only, 3% (4/160) used both loperamide
and activated carbon and 9% (14/160) used an antibiotic,
of whom most (9/14, 64%) used the antibiotic in combina-
tion with an anti-motility agent. Five travelers who used
an antibiotic (5/14, 36%) had been prescribed the antibio-
tic at the pre-travel consult. Loperamide was started a
median of 1 day (IQR 0-2 days) after onset of symptoms.
Antibiotics were started later (median 3 days after onset of
symptoms; IQR 2-5 days). In total eight travelers (8/160,
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two (2/160; 1%) were admitted to hospital in Africa with
fever, diarrhea, vomiting and dehydration. One hundred
and two travelers (102/390, 26%) reported non-travelers’
diarrhea related health problems: 13 vomiting without
diarrhea, 11 abdominal discomfort or loose stools that did
not fit the definition of TD, 6 constipation, 24 a respira-
tory tract infection, 19 a skin or eye infection, 3 a urinary
tract infections, 2 fever (1 unknown cause, 1 malaria), 12
headache or tiredness, and 12 some other health problem.
The following variables independently increased the
odds of contracting TD: younger age, use of an antacid,
longer travel duration, lower Human Development
Index of the country that was visited, backpacking as
type of travel and staying in luxury hotels. Travelers
whose main travel purpose was to visit friends/relatives
or who traveled for business/professional reasons had
reduced odds for contracting TD. Nagelkerke’sR
2 was
0.22, which means that the model accounted for 22% of
the variance in TD (Table 1).
Inconvenience due to travelers’ diarrhea
Although most travelers (107/160; 67%) could conduct
their activity program as planned despite having diarrhea,
21% (33/160) were forced to alter their program and an
additional 13% (20/160) were confined to their accom-
modation for one or more daylight days (median 1 day;
IQR 1-2 days). When asked about the degree of inconve-
nience brought on by the diarrheal illness, 39% (63/160)
categorized it as minor or none at all, 34% (54/160) as
moderate and 27% (43/160) as large or severe. Severity of
symptoms was greater and use of treatment and necessity
to alter the activity program were more common in those
who were incapacitated due to TD (Table 3). In a logistic
regression model, restricted to travelers who contracted
TD, none of the person- or travel-characteristics were
significantly (p < 0.05) associated with incapacitation due
to TD. The following symptoms independently increased
the odds of incapacitation due to TD: stool frequency,
nausea and fever (Table 4).
Before departure, we surveyed the incidence of diar-
rhea among participants during a two-month period in
The Netherlands; 22% answered that they had an epi-
sode of diarrhea according to our definition of (trave-
lers’) diarrhea. The normal stool pattern of these
participants may come close to fulfilling the definition
of TD, making these participants more likely to report
TD during travel without significant inconvenience.
Therefore, we performed a sensitivity analysis in which
we excluded these participants. This did not cause a
major change in the results. In the remaining subset
62% could conduct their activity program as planned,
27% were forced to alter their program and 10% were
confined to their accommodation. In another sensitivity
analysis restricted to 144 participants with classic TD,
65% could conduct their activity program as planned,
22% were forced to alter their program and 14% were
confined to their accommodation.
Not included 
  Did not want to participate  n = 370 
  Did not meet inclusion criteria  n = 224 
Completed second questionnaire         n = 390 
Did not complete second questionnaire 
  Lost to follow-up    n = 16 
Invited to participate    n = 1000 
Completed first questionnaire  n = 406 
Figure 1 Flowchart of participants in the study of inconvenience due to travelers’ diarrhea.
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Page 4 of 10Table 1 Travel characteristics and risk factors for travelers’ diarrhea in a cohort of 390 Dutch travelers.
Characteristic All n =
390
Classic TD n =
144
No TD n =
246
Univariate OR
[95% CI]
p-
value
Multivariate OR
[95% CI]
Relative contribution of each characteristic to the
model’sR
2 (%)
Gender, female
1 253 (65) 98 (68) 155 (63) 1.25 [0.81-1.93] 0.31
Age <
0.001
18.6
18-34 years 217 (56) 102 (71) 115 (47) 1.0 1.0
≥ 35 years 173 (44) 42 (29) 131 (53) 0.36 [0.23-0.56] 0.38 [0.23-0.65]
Use of an antacid
2 24 (6) 14 (10) 10 (4) 2.54 [1.10-5.88] 0.03 2.95 [1.14-7.60] 6.8
Born in the tropics
3 19 (5) 5 (3) 14 (6) 0.60 [0.21-1.69] 0.33
Traveled to the tropics in the
preceding 5 years
4
251 (64) 91 (63) 160 (65) 0.92 [0.60-1.42] 0.71
Mean travel duration - days (SE) 22.9 (0.65) 25.6 (1.2) 21.4 (0.7) 1.03 [1.01-1.04] 0.002 1.02 [0.99-1.04] 2.7
Travel destination, Human
Development Index
0.02 10.6
High 79 (20) 18 (13) 61 (25) 1.0 1.0
Medium 219 (56) 90 (63) 129 (54) 2.36 [1.31-4.27] 0.004 2.29 [1.22-4.33]
Low 92 (24) 36 (25) 56 (23) 2.18 [1.11-4.27] 0.02 2.51 [1.19-5.33]
Main travel purpose
5
Holiday 236 (61) 89 (62) 147 (60) 1.09 [0.72-1.66] 0.69
Visit friends/relatives 55 (14) 13 (9) 42 (17) 0.48 [0.25-0.93] 0.03 0.56 [0.27-1.19] 3.3
Business/professional 32 (8) 5 (4) 27 (11) 0.30 [0.11-0.81] 0.02 0.31 [0.11-0.88] 7.6
Study 51 (13) 29 (20) 22 (9) 2.57 [1.41-4.67] 0.002 1.16 [0.56-2.40] 0.2
Volunteer work 16 (4) 8 (6) 8 (3) 1.75 [0.64-4.77] 0.27
Type of travel
6
Self-arranged, not backpacking 170 (44) 56 (39) 114 (46) 0.74 [0.49-1.12] 0.15 1.17 [0.68-2.01] 0.4
Backpacking 85 (22) 44 (31) 41 (17) 2.20 [1.35-3.58] 0.002 1.89 [0.96-3.70] 4.5
Organized group travel 108 (28) 37 (26) 71 (29) 0.85 [0.54-1.36] 0.50
Other 27 (7) 7 (5) 20 (8) 0.58 [0.24-1.40] 0.23
Type of accommodation
7
Luxury hotel only 98 (25) 43 (30) 55 (22) 1.48 [0.93-2.36] 0.10 2.94 [1.64-5.29] 18.2
Budget hotel only 95 (24) 34 (24) 61 (25) 0.94 [0.58-1.52] 0.79
Camping (tent/camper) 26 (7) 9 (6) 17 (7) 0.90 [0.39-2.07] 0.80
Holiday home 15 (4) 5 (4) 10 (4) 0.85 [0.28-2.53] 0.77
Stayed with friends or relatives 12 (3) 3 (2) 9 (4) 0.56 [0.15-2.10] 0.39
Stayed with locals 13 (3) 8 (6) 5 (2) 2.84 [0.91-8.84] 0.07 2.91 [0.80-10.55] 3.4
Combination of the above
† 131 (34) 42 (29) 89 (36) 0.73 [0.47-1.13] 0.16
Diarrheal episode 2 months prior to
departure*
0.003
No 195/251
(78)
61/91 (67) 134/160 (84) 1.0
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0Table 1 Travel characteristics and risk factors for travelers?’? diarrhea in a cohort of 390 Dutch travelers. (Continued)
Yes 56/251
(22)
30/91 (33) 26/160 (16) 2.54 [1.38-4.65]
Subjective susceptibility for travelers’
diarrhea*
0.12
Never 104/251
(41)
33/91 (36) 71/160 (44) 1.0
Sometimes 121/251
(48)
44/91 (48) 77/160 (48) 1.23 [0.71-2.14] 0.47
Often/Always 26/251
(10)
14/91 (15) 12/160 (8) 2.51 [1.05-6.02] 0.04
Data are presented as n (%), unless otherwise stated. OR: odds ratio; SE: standard error of the mean; CI: confidence interval. P-values based on c
2-tests for categorical variables and t-tests for continuous variables.
Variables with p < 0.2 were included in the multivariate logistic regression model. Reference category:
1male gender,
2no use of an antacid,
3born in The Netherlands,
4not having traveled to the tropics in the
preceding 5 years,
5not the specified travel purpose,
6not the specified type of travel,
7not having stayed in the specified type of accommodation.
†Not included in the multivariate model because it is not a uniform
category. *Not included in the multivariate logistic regression model because subjects who had not traveled to the tropics in the past 5 years had missing values for these variables. Model: constant = 0.19,
Nagelkerke’sR
2 = 0.22, Hosmer and Lemeshow test for goodness of fit p = 0.4.
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0Table 2 Travelers’ diarrhea, incidence proportions and incidence rates for 390 Dutch travelers.
Travel destination Travelers -
n
TD cases -
n
TD incidence proportion - %
(SE)
Mean travel duration -
days
TD Incidence rate - per 100
pdt (SE)
Northern Africa 17 7 41 (12.3) 10.4 3.95 (1.47)
South-central Asia 31 16 52 (9.1) 20.2 2.55 (0.63)
Central America and
Caribbean
24 11 46 (10.4) 18.9 2.42 (0.72)
South-eastern Asia 121 61 50 (4.6) 22.5 2.25 (0.28)
Eastern Africa 57 25 44 (6.6) 23.4 1.88 (0.37)
Central Africa 7 3 43 (20.2) 23.4 1.83 (1.05)
Central and Western Asia 32 8 25 (7.8) 14.3 1.75 (0.61)
Western Africa 15 7 47 (13.3) 28.6 1.63 (0.61)
Southern Africa 15 4 27 (11.8) 23.1 1.16 (0.58)
Eastern Asia 36 11 31 (7.8) 29.4 1.04 (0.31)
South America 46 7 15 (5.4) 26.4 0.58 (0.22)
All travelers 401
† 160 41 (2.4) 22.4 1.78 (0.14)
pdt: person days of travel; SE: standard error.
†11 participants travelled to more than one destination. NOTE: Incidence rates were not corrected for the time to
first episode of TD or for the number of episodes of TD.
Table 3 Characteristics of the episode of travelers’ diarrhea for 160 Dutch travelers, stratified by the objective degree
of inconvenience.
Objective degree of
inconvenience - n (%)
Conducted program as planned
107/160 (67%)
Forced to alter program
33/160 (21%)
Confined to accommodation
20/160 (13%)
Total 160
(100%)
Stool frequency - n (%)
3 stools/day 64 (60) 11 (33) 1 (5) 76 (48)
4-5 stools/day 35 (33) 15 (46) 8 (40) 58 (36)
6-10 stools/day 7 (7) 6 (18) 9 (45) 22 (14)
> 10 stools/day 1 (1) 1 (3) 2 (10) 4 (3)
Watery stools, duration - n
(%)
No watery stools 20 (19) 1 (3) 1 (5) 22 (14)
1 day 37 (35) 11 (33) 4 (20) 52 (32)
2-3 days 31 (29) 14 (42) 8 (40) 53 (33)
4-7 days 10 (9) 5 (15) 5 (25) 20 (13)
> 7 days 9 (8) 2 (6) 2 (10) 13 (8)
Fecal urgency, duration - n
(%)
No fecal urgency 38 (36) 8 (24) - 46 (29)
1 day 30 (28) 10 (30) 7 (35) 47 (29)
2-3 days 22 (21) 10 (30) 6 (30) 38 (24)
4-7 days 11 (10) 3 (9) 1 (5) 15 (9)
> 7 days 6 (6) 2 (6) 6 (30) 14 (9)
Abdominal cramps, duration -
n (%)
†
No abdominal cramps 32 (30) 3 (9) 2 (10) 37 (23)
1 day 32 (30) 11 (33) 4 (20) 47 (29)
2-3 days 30 (28) 12 (36) 6 (30) 48 (30)
4-7 days 9 (8) 5 (15) 4 (20) 18 (11)
> 7 days 4 (4) 2 (6) 4 (20) 10 (6)
Nausea, duration - n (%)
No nausea 82 (77) 13 (39) 4 (20) 99 (62)
1 day 17 (16) 9 (27) 6 (30) 32 (20)
2-3 days 6 (6) 8 (24) 6 (30) 20 (13)
4-7 days 1 (1) 2 (6) 3 (15) 6 (4)
> 7 days 1 (1) 1 (3) 1 (5) 3 (2)
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Page 7 of 10Before departure all travelers were asked the following
question: “If you were to contract travelers’ diarrhea with
fecal urgency and abdominal cramps for three days, how
large a problem would you consider this to be?”.A f t e r
returning home all travelers were presented a similar sce-
nario. Table 5 shows that the distribution of participants’
answers did not shift in those who did not contract TD
(p = 0.6, Wilcoxon signed rank test for two-related sam-
ples, comparison of the distribution of two variables).
However, those who did contract TD tended to consider
TD a smaller problem when asked the question upon
return than they had thought it would be prior to depar-
ture (p < 0.001). Surprisingly, even the participants who
were forced to alter their planned activities (p = 0.01)
and the participants who were forced to stay indoors (p =
0.03) tended to consider TD less of a problem when
asked the question upon return than they had thought it
would be before departure.
Discussion
This study was specifically designed to measure the degree
of inconvenience brought on by TD. We found that
approximately one-third of travelers who contracted TD
were forced to change their activity program or stay
indoors, which is in line with other reports [2,3,13-15].
Two travelers were even admitted to hospital. Two-thirds
did not need to change their activity program and a size-
able proportion (39%) said that the episode of TD caused
only minor inconvenience. Those who reported minor
inconvenience seldom used an anti-diarrheic agent mean-
ing that the reported degree of inconvenience in this sub-
group was not significantly influenced by treatment. As it
Table 3 Characteristics of the episode of travelers?’? diarrhea for 160 Dutch travelers, stratified by the objective
degree of inconvenience. (Continued)
Vomiting - n (%)* 13 (12) 12 (36) 7 (35) 32 (20)
Fever - n (%) 6 (6) 8 (7) 11 (55) 17 (11)
Treatment - n (%)
Loperamide 29 (27) 11 (33) 14 (70) 54 (34)
Activated carbon 3 (3) 6 (18) 2 (10) 11 (7)
Antimicrobial agent 3 (3) 6 (18) 5 (25) 14 (9)
Subjective degree of
inconvenience - n (%)
None/Minor 58 (54) 5 (15) - 63 (39)
Moderate 33 (31) 13 (39) 8 (40) 54 (34)
Large/Severe 16 (15) 15 (46) 12 (60) 43 (27)
*13 additional travelers who did not have diarrhea reported vomiting;
†10 additional travelers who did not have travelers’ diarrhea according to the definition,
reported abdominal cramps.
Table 4 Logistic regression model evaluating which symptoms best predicted incapacitation due to travelers’ diarrhea.
Characteristic All with TD n =
160
Conducted program as planned
n = 107
Incapacitated n
=5 3
Univariate OR
[95% CI]
p-
value
Multivariate OR
[95% CI]
Stool frequency <
0.001
3 stools/day 76 (48) 64 (60) 12 (23) 1.0 1.0
4-5 stools/day 58 (36) 35 (33) 23 (43) 3.51 [1.56-7.88] 2.05 [0.77-5.43]
> 5 stools/day 26 (16) 8 (8) 18 (34) 12.0 [4.26-33.8] 4.84 [1.40-16.8]
Abdominal cramps 0.005
No abdominal
cramps
37 (23) 32 (30) 5 (9) 1.0 1.0
1 -3 days 95 (59) 62 (58) 33 (62) 3.41 [1.21-9.57] 1.86 [0.55-6.34]
> 3 days 28 (18) 13 (12) 15 (28) 7.39 [2.22-24.5] 2.64 [0.62-11.3]
Fecal urgency
1 114 (71) 69 (65) 45 (85) 3.10 [1.32-7.25] 0.009 0.93 [0.32-2.70]
Nausea
2 61 (38) 25 (23) 36 (68) 6.95 [3.35-14.4] <
0.001
4.38 [1.70-11.3]
Vomiting
3 32 (20) 13 (12) 19 (36) 4.04 [1.80-9.06] 0.001 0.96 [0.32-2.91]
Fever
4 25 (16) 6 (6) 19 (36) 9.41 [3.47-25.5] <
0.001
5.65 [1.80-17.7]
TD: travelers’ diarrhea; OR: odds ratio; CI: confidence interval. P-values based on c
2-tests for categorical variables. Variables with p < 0.2 were included in the
multivariate logistic regression model. Reference category:
1no fecal urgency,
2no nausea,
3no vomiting,
4no fever. Model: constant = 0.06, Nagelkerke’sR
2 = 0.42,
Hosmer and Lemeshow test for goodness of fit p = 0.7.
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Page 8 of 10is to be expected, the severity of symptoms was greater in
those who regarded the episode of TD a major inconveni-
ence. The travelers’ perception of TD changed based on
the current experience. Travelers who contracted TD con-
s i d e r e di tl e s so fap r o b l e mi nretrospect than they had
thought it would be before departure. Surprisingly, this
was even true for those who were forced to change their
plans and for those who had to stay indoors. Although
this finding may simply mean that travelers are less appre-
hensive about problems they have faced before, it suggests
that TD is less of a nuisance than travelers expect
beforehand.
Most risk factors for contracting TD were in line with
recent reports. Unexpectedly, we found that staying in lux-
ury hotels increased the odds for contracting TD. Travel
duration for participants who stayed in luxury hotels was
shorter and they were more likely to have traveled to high
risk destinations, such as Indonesia and Egypt (data not
shown). Residual confounding due to incomplete adjust-
ment for destination and for the time to the first episode
of TD may account for (part of) the unexpected associa-
tion between accommodation in luxury hotels and TD.
Alternatively, staying in luxury hotels may be associated
with consumption of more elaborate food which bears
more risks [13].
This study has a number of strengths. First, participants
were recruited before departure. This way we aimed to
limit the chance of preferentially selecting travelers with
more severe TD who may be more inclined to respond to
a questionnaire taken after the facts. Secondly, surveying
travelers both before- and after travel, enabled analysis of
how travelers’ perception of TD changed depending on
whether or not TD was contracted during travel. Thirdly,
nearly all participants completed both questionnaires,
further limiting the chance of bias. Lastly, we measured
both the objective and subjective degree of inconvenience.
Participants’ reporting of both kinds of inconvenience was
consistent, which shows that the data are robust. The
study also has limitations. First, although we piloted the
questionnaire among travelers, acquaintances and
epidemiologists, questions could have been misinterpreted.
To limit the chance of misinterpretation, participants
could contact us by e-mail in case of any ambiguity. We
also provided ample opportunity for participants to further
specify answers. For example, those who reported that
they had to change their activity program or remain
indoors due to TD were requested to describe which activ-
ities were cancelled. Secondly, the normal stool pattern of
some participants may come close to fulfilling the defini-
tion of TD, making these participants more likely to report
TD without significant inconvenience. This may have led
to an underestimation of the inconvenience associated
with ‘real TD’. However, two sensitivity analyses in which
such participants were excluded did not yield different
results. Therefore it is unlikely that we underestimated the
inconvenience associated with TD during the stay abroad.
Thirdly, many travelers used an anti-motility agent or an
antibiotic to treat TD. It stands to reason that the degree
of inconvenience would have been larger if nobody had
used treatment and would have been smaller if all had
used treatment. Lastly, TD incidence rates were not cor-
rected for the time to the first episode of TD or for the
number of episodes. This may have inflated incidence
rates for destinations for which travel duration was longer
than average and deflated incidence rates for destinations
for which it was shorter than average.
Most cases of TD in this study fitted the classic defini-
tion of TD. Overall incidence rates and risk factors were
in line with recent reports [1,3,13,14,23]. These aspects
increase the generalizability of this study. Some aspects
limit the generalizability. Firstly, the study population
consisted mainly of Dutch born nationals. Dutch people
m a yb em o r ei n c l i n e dt oa w a i tt h en a t u r a lc o u r s eo fa
self-limiting illness than travelers from other countries
[24]. This could influence the way in which they perceive
TD as a problem. However, such cultural differences
would probably not impact the objective degree of incon-
venience. Secondly, participants were recruited at our
travel clinic. The results may not be representative of tra-
velers who do not seek health-related travel advice before
Table 5 How did an episode of travelers’ diarrhea (TD) influence travelers’ perception of TD? The expected amount of
subjective inconvenience due to travelers’’ diarrhea before and after travel is stratified by whether travelers had TD.*
Travelers who had TD n = 160 Travelers who did not have TD n = 230
Before departure After returning Before departure After returning
No problem - n (%) 1 (1) 11 (7) 1 (0.4) 3 (1)
A small problem - n (%) 22 (14) 42 (26) 50 (22) 53 (23)
Neither a small nor a large problem - n (%) 51 (32) 56 (35) 61 (27) 57 (25)
A large problem - n (%) 69 (43) 49 (31) 99 (43) 99 (43)
A very large problem - n (%) 17 (11) 2 (1) 19 (8) 18 (8)
*Participants were presented the following scenarios: Before departure: If you were to contract travelers’ diarrhea during the coming journey, with a duration of
three days accompanied by urgency and abdominal cramps, how large a problem do you think this would be for you? After returning: If you were to make the
exact same journey in the future and you were to contract travelers’ diarrhea with a duration of three days accompanied by urgency and abdominal cramps,
how large a problem do you think this would be for you?.
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Page 9 of 10travel. Furthermore, the response rate was 50%. The
demographic features of those who refused to participate
may be different. Lastly, although the majority of visitors
to our hospital based travel clinic can be classified as
‘general travelers’, relatively more hospital employees and
(bio)medical students visit our travel clinic compared
with other out-of-hospital based travel clinics.
Conclusion
This study shows that conventional definitions of TD
encompass many cases of mild TD (in our study at least
a third of all cases) for which vaccination or antibiotic
treatment is unlikely to provide a significant health ben-
efit. By measuring the degree of inconvenience brought
on by TD, researchers and policy makers may be able to
better distinguish ‘significant TD’ from mild TD, thus
allowing for a more precise estimation of the size of the
target population for vaccination or stand-by antibiotic
prescription and of the benefit of such measures. We
suggest that a future study should investigate to what
extent routine stand-by antibiotic prescription impacts
on the subjective and objective degree of inconvenience
d u et oT Da sw e l la st h ei n c i d e n c eo fc h r o n i cg a s t r o -
intestinal complaints. This could be done by randomiz-
ing a similar group of travelers at the pre-travel consult,
either to receive a stand-by antibiotic prescription or
not.
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